COVID Vaccine Transition Planning: Price Does Not Come Up At ACIP
• By Michael McCaughan
Despite the headlines, policymakers see considerable ongoing value in COVID vaccinations even at the planned commercial prices. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images